Latest News and Press Releases

The complaint alleges Nidec revealed multiple cases of improper accounting, triggering investigations and steep ADR declines following several disclosures.

Defendants allegedly misled investors about Synopsys’s AI focus hurting its Design IP business, leading to weak Q3 results and a 35.8% stock drop.

Defendants allegedly misled investors by overstating Quantum’s revenue and operations, requiring a Q3 restatement and causing investor losses.

Defendants allegedly misled investors on Tronox’s forecasts, causing a 38% stock drop after Q2 results showed weaker sales and lowered guidance.

Defendants allegedly inflated the Wildermuth Fund’s asset values and hid failing investments, causing excessive advisory fees and harming investors.

Defendants allegedly hid Avantor’s weakening competitive position and lost accounts, leading to weak Q3 results, a $785M charge, and a 23% stock drop.

Insperity missed Q2 estimates with EPS of $0.26, down 70% year over year, cut guidance, and cited higher benefit costs, sending shares down 24.35%.

Simulations Plus missed Q3 estimates, reported a $77.2M impairment and lower guidance, and announced restructuring, causing shares to fall 25.76%.

Telix disclosed an SEC subpoena over its prostate cancer drug disclosures, causing its ADRs to fall 10.44% to $14.58 on July 23, 2025.

PetMed delayed its Q4 and FY2025 earnings release to complete its year-end audit, causing the stock to fall 11.22% to $3.72 on June 11, 2025.